Picture of Kaneka logo

4118 — Kaneka News Story

0.000.00%
jp flag iconLast trade - 00:00
Basic MaterialsConservativeMid CapSuper Stock

Inovio signs COVID-19 vaccine manufacturing deal with Japan's Kaneka

Dec 3 (Reuters) - Japan's Kaneka Corp  4118.T  has entered
into a deal to manufacture Inovio Pharmaceuticals Inc's  INO.O 
COVID-19 vaccine candidate, the U.S.-based vaccine maker said on
Thursday.
    It did not disclose the terms of the agreement with Kaneka
Eurogentec, a unit of the Japanese chemical company. 
    Inovio has also signed manufacturing deals with medical
device maker Thermo Fisher Scientific  TMO.N  among others, to
increase supply of the vaccine, which entered a mid-stage study
last month.
    The Phase 3 of the mid-to-late stage study is under a
partial hold by the U.S. Food and Drug Administration as it
seeks more information, including details on a delivery device
used to inject genetic material into cells.

 (Reporting by Amruta Khandekar; Editing by Shinjini Ganguli)
 ((Amruta.Khandekar@thomsonreuters.com;))

Recent news on Kaneka

See all news